MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

MarketsandMarkets is here with a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2023 Confex on the 8th - 9th February 2023 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.

The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product & drug development various small innovative players are operating in the market.

However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on microbiome vs probiotics and the link between them.

The healthcare sector is accelerating on a trajectory from ubiquitous treatment to truly personalized treatment. The advent of precision medicine has paved ways for customization and preventive health strategy development by utilizing the genetic information of the individual along with ethnicity, environment exposures, medical history and more. Surging trends in tailoring care have been a driving force for extensive research in this field from data research to target drug discovery.

With the advent of new technological advancements in medical research and diagnostic strategies, early disease diagnosis and prevention has witnessed a medical revolution. We are proud to present to you our ‘OncoGene’ ConfEx in London scheduled on 9th – 10th March 2023. This ConfEx is an assemblage of 3 inextricably linked conferences like 7th Annual Next-Gen Immuno-Oncology Conference, Next-Gen Genomics and Proteomics Conference and Precision Medicine Conference which will accommodate diverse sessions on cutting edge discussions via Presentations, Exhibitions, Speaker QnAs, Panel discussions or Breakout sessions.

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 9th - 10th March 2023, in London, would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

Leading our way back to the ambitious research collaboration, Human Genome Project has paved ways in transforming biology and biological discovery. As a result of which, the fundamentals of Genomics and Proteomics have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. The swift growth in high throughput technologies used for genomic and proteomic profiling has factored breakthroughs for a much-anticipated personalized medicine approach for complex diseases.

With the advent of new technological advancements and surgical techniques, minimally invasive surgery has witnessed a robotic revolution in the field of surgery in the form of Da Vinci robotic systems making MIS procedures a widely accepted standard of care for most of the clinical specialities all over the world. We are proud to present to you our 2nd Annual MarketsandMarkets Minimally Invasive Surgery Conference (6 streams) in London, scheduled on 20th – 21st March 2023.

MarketsandMarkets is here with a platform for Scientists, Microbiologists, Biologists, Pathologists and Researchers to come together at the PathDx 2023 Confex on 23rd – 24th March 2023 in London. An opportunity to discuss future insights, innovations and research ideas with advanced solutions to the most challenges in infectious disease diagnostics, molecular diagnostics and digital pathologies verticals.

MarketsandMarkets is proud to announce it’s 7th Annual Infection Control, Sterilization & Decontamination in Healthcare Conference scheduled for 23-24 March 2023 in London, UK.

This Congress aims to bring together all the stakeholders, to discuss the challenges in achieving and maintaining an infection free environment in the hospital settings in addition to effective and evidence based ways to reduce the risks of the emergence of healthcare-associated infections through fomites and medical equipment because of substandard infection prevention and control practice and contaminated medical devices.

It has been evident that for the past few decades there have been advances in Diagnostic technologies which have opened doors for early diagnosis & prevention.
MarketsandMarakets is proud to present to you the 4th Annual MarketsandMarkets Infectious Diseases and Molecular Diagnostics, scheduled to be on 23rd – 24th March 2023, in London. The event is created and shaped with presentations on the topics like Future Molecular Diagnostics and New Diagnostic Technologies, how the timely recognition of various viral diseases would prevent the spread to a great extent by use of Advanced Diagnostic Technologies, advances in lab-on-a-chip technologies, and many more.

Globally focused on education, tissue-based research, medication development, and human pathology practice. 

Looking and the current market scenario, many companies are outsourcing the manufacture of their highly potent compounds for various reasons, mainly marketing. The escalation in the High Potent drug market is subjected to a variety of aspects such as the diversification of pharmaceutical manufacturers towards precision medicines such as HPAPI, increasing demand for oncology drugs & antibody-drug conjugates, and advancements in HPAPI manufacturing technologies.
 

The competitive dynamics of organizations worldwide are rapidly evolving, with industrial processes being reshaped & resized by various disruptive forces in the form of novel technological advancements, regulatory policies, unique business models and the potential of newer competitive entrants. With these changes afoot, the role of a Chief Strategy Officer has risen to the forefront.

A neoteric breakthrough in Precision Medicine has been acclaimed as the steppingstone in disease prediction and prevention strategies. This integral change in our approach to medication therapy has federal efforts in developing the ‘’Hyperindividualised’’ therapy while taking into account the genetic patterns, drug responses, lifestyle and cultural environment.

Our 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 22nd - 23rd June 2023, in Boston, would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 22nd - 23rd June 2023 in Boston, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key to making treatment decisions, it needs to be quicker, more precise, and more accurate.

Market intelligence provides a comprehensive perspective of any industry's depth, both economically and philosophically. Organizations cannot afford to scrimp on acquiring market knowledge in today's fast-paced economy. Missing on these advantages can be the difference between success and failure.

The competitive dynamics of organizations worldwide are rapidly evolving, with industrial processes being reshaped & resized by various disruptive forces in the form of novel technological advancements, regulatory policies, innovative business models and the potential of new competitive entrants. With these changes afoot, the role of a Chief Marketing Officer has risen to the forefront.

With the advent of neural implants and novel therapies, the cure of multiple neurodegenerative disorders proves wholesome for the patients’ suffering. Increasing in the severity of neurodegenerative diseases, demands the discovery of new translational approaches in neuroscience research.

MarketsandMarkets is proud to announce the 6th Annual Real-World Evidence and Life Sciences Conference to be held on October 16th - 17th, 2023 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2023.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

Looking and the current market scenario, many companies are outsourcing the manufacture of their highly potent compounds for various reasons, mainly marketing. The escalation in the High Potent drug market is subjected to a variety of aspects such as the diversification of pharmaceutical manufacturers towards precision medicines such as HPAPI, increasing demand for oncology drugs & antibody-drug conjugates, and advancements in HPAPI manufacturing technologies.

In recent years, digital pathology has become a well-established technology. Globally focused on education, tissue-based research, medication development, and human pathology practice.

Plant-based foods are one of the fastest growing food categories, growing by double digits since 2019, and are expected to reach $68.4 billion worldwide by 2026. The growth of this market is driven by a wide range of factors, including the increasing intolerance for animal proteins among consumers, the growing vegan population, and the booming number of venture investments in plant-based foods. Further, the increasing number of new products developed by manufacturers of plant-based proteins and emerging economies, such as Asian-Pacific, Latin America, and Middle East & Africa, are expected to provide new opportunities for players in this market.

Agriculture is a major economic sector for any country.  It is integral to our very existence. Emerging trends in Agriculture are one of the primary drivers of the sector's expansion. Emerging agricultural trends involve new technologies and strategies that become more advanced over time. There have been significant changes in the agriculture sector over the past several decades and new technologies have also been introduced. All these factors have led to an expansion of the sector. Recent agricultural advances have made farming activities more comfortable and acceptable for farmers. Developments or trends such as these benefit not only the growth of agriculture, but also the lives of farmers.